Name | Value |
---|---|
Revenues | 101.5M |
Cost of Revenue | 49.2M |
Gross Profit | 52.3M |
Operating Expense | 50.0M |
Operating I/L | 40.6M |
Other Income/Expense | -31.1M |
Interest Income | 0.0M |
Pretax | 9.5M |
Income Tax Expense | -0.9M |
Net Income/Loss | 10.4M |
Procaps Group S.A. is a global pharmaceutical company that develops, manufactures, and markets a wide range of branded prescription drugs and over-the-counter (OTC) consumer healthcare products. Its product portfolio includes drugs for various therapeutic areas such as feminine care, pain relief, skin care, digestive health, cardiology, vision care, central nervous system, and respiratory. The company also offers hospital-use drugs, including antibiotics, blood clot, personal protective equipment, immunosuppressants, oncology, and analgesics products. Additionally, Procaps provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions. It also specializes in soft gelatin capsule technologies and offers contract drug development and manufacturing services to third-party pharmaceutical companies.